Aqueous polymer solutions that are transformed into gels by changes in environmental conditions, such as temperature and pH, thus resulting in in-situ hydrogel formation, have recently attracted the attention of many investigators for practical biomedical or pharmaceutical applications.
-indicates not present.
ated by following a reported agar plate method. 8) In Vitro Drug Release Studies In vitro drug release 9) from the gelling formulations was studied by dialysis (membrane thickness 0.025 mm) against phosphate buffer pH 6.6 as the diffusion medium. Aliquot samples were withdrawn at regular intervals and analysed by spectrophotometry at 322 nm. The release data were analysed according to the treatment proposed by Higuchi.
10)
Anti-inflammatory Activity in Rats In vivo anti-inflammatory studies of KT based formulations were conducted in male Wister rats by following a reported 11) method. The study protocol was approved by the Institutional Animal Ethical Committee. All the nasal formulations (batches D1, D4 and P4) were delivered to the nasal cavity via inserted tracheal cannula using a microsyringe attached to a blunt needle.
12) Also, for comparision, KT (2 mg/kg in each case) administration to rats was done through oral intubation, intraperitoneal injection and nasal instillation as aqueous solution.
12)
Histopathology Studies After the pharmacodynamic studies, the rats used for nasal gel (batch D4) treatment, were euthanized with an intravenous injection of lethal dose of pentobarbitone sodium. The medial part of the septum was surgically removed and immersed in fixative for 30-45 min in 6% formaldehyde solution. The specimens were decalcified in 10% (v/v) formic acid overnight, cut into 2-3 pieces and embedded in paraffin wax. The embedded tissues were sectioned, stained with haematoxylin-eosin (H&E) followed by periodic acid-Schiff staining (PAS) 13) and evaluated semi-quantitatively (single blinded study) for epithelial hyperplasia, goblet cell hyperplasia, and neutrophil infiltrations of (i) stroma, (ii) epithelium and (iii) lumen of the nasal cavity. For comparative analysis of mucous irritation potential, three different groups were taken, one group was untreated rats (no nasal administration), second was treated with nasal normal saline and third was treated with sodium taurodihydrofusidate (STDHF, 1% (w/v)) in normal saline. 14) All were euthanized as above and their respective nasal mucosal staining was done by following the above staining procedures.
Stability Studies To assess long term stability 15) of the prepared gelling systems of KT, formulations were stored at 40°C/75% relative humidity (RH) in the stability chamber for 3 months. The samples were withdrawn at different time intervals (0, 1, 3 months) and observed for physical characteristics, drug content and in vitro drug release characteristics. The results were supported by statistical analysis using student 't' test and ANOVA (significance level pϽ0.05).
Results and Discussion
Physical characteristics of prepared gelling systems of KT are shown in Table 2 . All the prepared solutions were in pH range of 3.8-4.9. pH Ͻ5 provides a better environment for mucoadhesion as well as longer retention of formulation in the nasal cavity because of hydrogen bonding. The drug content of all the prepared formulations was found within a range of 97.55 to 99.64% (Table 2) .
Gelation and Gelling Capacity The gelation temperatures of chitosan (batches D1-D6) and pectin (batches P1-P6) gels were in the range of 35.0 to 37.4°C and 35.3 to 36.8°C, respectively ( Table 2 ). All the prepared formulations gelled immediately and remained as gels for longer time ( Table 2) .
Addition of HPMC in both chitosan and pectin based gelling systems increased the viscosity and gel strength (batches D5, D6 and P5, P6). The higher gelation rate of the formulation with HPMC might have resulted from the stronger association of HPMC with other components via hydrogen-bonding, 16) leading to a prolonged retention of KT in the nasal cavity.
17) It was also observed that an increase in HPMC content resulted in marginal increase in gelation temperature (Table 2 ). This might be caused by the increased viscosity due to the additional mucoadhesive polymer.
Rheological Studies The formulations exhibited pseudoplastic rheology as evidenced by shear thinning and an increase in the shear stress with increased angular velocity ( Table 2 ). The viscosity was directly dependent on the polymeric content of the formulations. Addition of HPMC led to increase in the viscosity of formulations and exhibited more pseudoplasticity (batches D5, D6 and P5, P6) as compared to batches prepared without HPMC (Table 2) .
In Vitro Bioadhesion The results indicated a reverse relationship between the force of adhesion of the gels and their movement on the agar ( Table 2) . The higher mucoadhesivity shown by the batches of chitosan containing gels (batches D1-D6) is in accordance with findings reported by Park et al. 18) and chitosan being a cationic polyelectrolyte binds strongly with mucin which is an anionic polyelectrolyte at neutral pH. 19) Pectin, being an anionic polymer, it also showed a better bioadhesiveness ranged from 70.32% (batch P5) to 78.36% (batch P4) ( Table 2 ). However, incorporation of neutral polymer HPMC, increased the viscosity but failed to enhance the bioadhesivity significantly. This might be due to availability of low amount of water for swelling of HPMC and chitosan combination in the agar plate. 8) In Vitro Drug Release The release profiles of KT observed from all the gelling formulations exhibited a biphasic pattern of drug release (Figs. 1, 2) . The results (Fig. 1) of the in vitro studies indicated that the duration of drug release was significantly prolonged (pϽ0.01, student 't' test; pϽ0.05, one way ANOVA), with an increase in the chitosan (Fig. 1a) or pectin (Fig. 1b) concentration from 10 to 15% (w/v) and then to 30% (w/v), which may be attributed to increase in the polymer matrix densities as well as viscosity ( Table 2 ). However, increasing pectin concentration (Fig. 1b) from 30% (batch P3) to 40% (w/v) (batch P4) did not show much difference in prolonging the drug release. The release profiles also showed (Fig. 1b) that pectin 10% (batch P1) released total amount of drug within 4 h when compared to chitosan 10% (w/v) based gelling formulation (batch D1) which released 98.67% drug in 5 h of study. The amount of drug released at the end of 6 h from HPMC incorporated batches (Fig. 2) were 84% and 76% for D5 and D6, respectively. These values were much lower when compared to batches without HPMC (94%, 89% for D3, D4, respectively). This indicated that the incorporation of co-polymer HPMC could be an added advantage for prolonging the drug release from gelling systems. The same types of profiles were also seen with pectin based gelling formulation. Incorporation of HPMC in the pectin based gelling formulations (batches P5, P6) also showed significantly prolonged drug release when compared to batches without HPMC (batches P3, P4). To understand the mechanism of drug release from gelling systems, the results were further analyzed according to equation described by Peppas and Buri. 20) All the formulated gels exhibited diffusion-controlled drug release (nϭ0.3498-0.5119 for batches D1-D4 and 0.2816-0.5404 for batches P1-P4).
Stability Studies The chitosan and pectin based gels (batches D1, D4 and P4) exhibited no significant difference (pϾ0.05) in the drug content and in vitro release characteristics before and after storage for 1 and 3 months (40°C/75% RH, results not shown). However, there was a marginal decrease in viscosity with increase in temperature. This is in agreement with earlier report.
21)
Anti-inflammatory Activities in Rats All three gelling systems (batches D1, D4 and P4) inhibited rat paw oedema significantly in comparison to nasal and oral drug solution and intraperitoneal injection of KT. On increasing chitosan concentration from 10% (batch D1) to 30% w/v (batch D4), significantly (pϽ0.001) increased magnitude and duration of anti-inflammatory activity (Fig. 3) was observed. When compared with pectin based gelling systems (batch P4), chitosan based gelling systems (batch D4) prolonged the anti-inflammatory activity for 7 h as compared to 5 h from P4. This might be due to stronger bioadhesion 22) between mucus (anionic) and chitosan (a cationic polymer) as compared to mucus and pectin (an anionic polymer) interaction.
The relative bioavailability of nasal gelling systems D1, D4 and P4 were 365, 424 and 301% respectively in reference to per oral solution and were 151, 175 and 124% respectively in reference to intraperitoneal injection of drug.
Histopathological Studies The results shown in Fig. 4 and Table 3 indicated that the medial region of nasal septum of untreated rats was covered with typical respiratory epithelium (Fig. 4a) . The epithelia of the STDHF treated groups exhibited epithelium disruption and complete loss of some parts of the epithelium (Fig. 4b) . In contrast, only slight changes were observed in the epithelium of the groups exposed to nasal gel (batch D4) (Fig. 4c) . Nasal toxicity scores presented in Table 3 also showed that bioadhesive gelling system (batch D4) produced only mild irritation to nasal mucosae which could be reversible when compared to control groups. But, STDHF showed a severe damage to nasal mucosa.
It was concluded that the developed chitosan and pectin based bioadhesive gelling systems of KT were able to provide better deposition, distribution and residency properties of formulation in the nasal cavity and also exhibited prolonged drug release characteristics with added advantages of providing controlled anti-inflammatory effect with almost negligible irritant and toxic effects to nasal mucosae. Thus, bioadhesive gelling systems can be considered as a viable alternative for systemic medication of drugs through nasal route. 
